MIM-D3

· Mimetogen Pharmaceuticals USA, Inc.

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for MIM-D3, covering 2019-08-19 to 2019-08-19. Get the full timeline:

Most recent: Clinical Trial Update: A Safety and Efficacy Study of MIM-D3 Ophthalmic Solution for the Treatment of Dry Eye [Phase 3]